WinRho SDF

NABI Reimbursement Program for WinRho Patient Guide: How to Get WinRho SDF at Low or No Cost

WinRho SDF (Rho(D) Immune Globulin Intravenous (Human)) is a specialized medication used to treat immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, leading to low platelet counts and increased bleeding risk. The NABI Reimbursement Program for WinRho, offered by NABI (Nabi Biopharmaceuticals), helps eligible patients access this drug at low or no cost by covering expenses for those who qualify based on income and lack of insurance coverage.[1]

About WinRho SDF

WinRho SDF is indicated for non-splenectomized, Rh o(D)-positive patients needing to raise platelet counts to prevent excessive bleeding. It treats:

• Children with chronic or acute ITP
• Adults with chronic ITP
• Children and adults with ITP secondary to HIV infection[1][7]

Administered intravenously (IV) over 3-5 minutes, it's available in vials like 1500 IU (300 mcg), 2500 IU (500 mcg), and others. Dosing is weight-based, e.g., 250 IU/kg (50 mcg/kg) initially, with monitoring of platelet counts, hemoglobin (Hgb), and other labs post-infusion. Patients must have Hgb ≥8 g/dL; reduced doses apply for Hgb 8-10 g/dL. It's often used as bridge therapy when switching treatments.[3][6][7]

Important Safety Note: Monitor for intravascular hemolysis (IVH) for at least 8 hours after infusion. Ensure patients are not volume-depleted, and use caution in those at risk for renal issues.[1][3]

Who Qualifies for the NABI Reimbursement Program?

This program targets patients facing financial barriers to WinRho SDF. Key eligibility:

• Medical Need: Prescription for WinRho SDF to treat eligible ITP conditions.
• Income Limits: Household income at or below 200% of the Federal Poverty Level (FPL). No specific thresholds listed for individual, couple, family of 3, or 4—use 200% FPL guidelines.
• Insurance Status: Patients without prescription coverage, including those with Medicare Part D.[program data]

Income Eligibility Breakdown

Use the U.S. Department of Health & Human Services (HHS) FPL guidelines (updated annually). Here's a sample table for 2026 (check current at aspe.hhs.gov/poverty-guidelines for exact figures):

Add ~$5,380 per additional person for 100% FPL, double for 200%. Income includes all sources; deductions may apply.[program data]

Insurance Requirements

The program is for uninsured patients or those lacking prescription drug coverage. It explicitly includes Medicare Part D enrollees without adequate coverage for WinRho. If you have private insurance, commercial plans, or other coverage that pays for WinRho, you may not qualify. Contact the program to confirm.[program data][1]

Step-by-Step Application Process

The program supports multiple application methods for flexibility. While specific forms aren't listed, follow these general steps based on standard PAP processes and manufacturer contacts:[program data][1][2]

1. Get a Prescription: Ask your doctor to prescribe WinRho SDF and discuss if you qualify for assistance.
2. Check Eligibility: Verify income ≤200% FPL and no prescription coverage. Gather proof.
3. Contact the Program: Call Customer Service at 1-833-779-2614 (toll-free) or email gmb-sps-kamada@cardlogistics.com for forms, guidance, and reimbursement questions. Mention 'NABI Reimbursement Program'.[1]
4. Complete Application: Applications available via phone/email or download from sites like PrescriberPoint.[2] Provide:
   • Proof of income (tax returns, pay stubs, etc.)—no specific documents mandated, but standard proofs required.[program data]
   • Proof of no prescription insurance.
   • Doctor's prescription and medical records confirming ITP diagnosis.
   • Patient ID info.
5. Submit: Fax, mail, or upload as instructed. Your doctor/pharmacy may handle reimbursement claims using J-code J2792.[1]
6. Follow Up: Track status via contact number.

Timeline and Delivery

Processing time not specified—typically 2-4 weeks for PAPs, but call for updates. Once approved, WinRho is ordered via major wholesalers (e.g., McKesson, Cardinal) using NDC codes like 49591-330-51. Delivery method varies; often shipped to your pharmacy, doctor's office, or home. Infusion occurs IV in a clinical setting—not self-administered.[1][3]

Alternatives if Denied or Biosimilars

If denied (e.g., income too high or insured), consider:

• Biosimilar Alternatives: Hyperrho or Rhophylac—similar Rho(D) immune globulins for ITP.[program data]
• Other PAPs or copay cards via PrescriberPoint.[2]
• Ryan White programs for HIV-related ITP.[4]
• VA formulary if eligible.[5]
• Doctor may suggest other ITP treatments like steroids or splenectomy.

Disclaimer

This guide is for informational purposes only and based on available program data as of 2026. Eligibility, terms, and contacts can change—always verify directly with NABI at 1-833-779-2614 or gmb-sps-kamada@cardlogistics.com. Not medical advice; consult your doctor for treatment. WinRho has risks like IVH, renal issues—review full safety info.[1][6] Word count: 950.